Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure

Z. Abassi, A. Haramati, A. Hoffman, John C Jr. Burnett, J. Winaver

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Increased activity of the renin-angiotensin system is thought to play a major role in the pathogenesis of salt retention and edema formation in congestive heart failure. The present study evaluates the effects of chronic inhibition of angiotensin-converting enzyme on the response to infusion of exogenous atrial natriuretic factor (ANF) in salt-retaining rats with chronic arteriovenous (a-v) fistula, an experimental model of high-output congestive heart failure. Administration of ANF in incremental doses (5-50 μg·kg-1·h-1) to Inactin-anesthetized, sham-operated control rats resulted in dose-dependent increases in flow, sodium excretion, and glomerular filtration rate, and significant decreases in mean arterial blood pressure. These effects of atrial peptide were markedly attenuated in salt-retaining rats with a-v fistula. However, chronic oral treatment with the angiotensin-converting-enzyme inhibitor enalapril restored the natriuretic response of sodium-retaining rats with a-v fistula to high doses of ANF. At a dose of 50 μg·kg-1·h-1, fractional excretion of Na (FE(Na) in a-v fistula rats given enalapril was 4.0 ± 0.5%, which was significantly greater than that in a-v fistula rats without enalapril (0.5 ± 0.4%, P < 0.05) and not different from the response in sham-control rats (4.9 ± 0.7%). The improvement in the natriuretic response after enalapril was not associated with a significant increase in GFR and occurred despite a decrease in mean arterial pressure. Moreover, chronic enalapril treatment did not significantly alter the plasma levels of immunoreactive ANF in either the sham controls or in the rats with a-v fistula. These data demonstrate that chronic converting-enzyme inhibition restores the natriuretic action of synthetic ANF in anesthetized rats with experimental heart failure. The data further suggest that increased activity of the renin-angiotensin system plays an important role in mediating the blunted natriuretic response to ANF in this experimental model of heart failure.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume259
Issue number1 28-1
StatePublished - 1990
Externally publishedYes

Fingerprint

Heart Failure
Arteriovenous Fistula
Atrial Natriuretic Factor
Enalapril
Kidney
Enzymes
Arterial Pressure
Salts
Renin-Angiotensin System
Theoretical Models
Sodium
rat atrial natriuretic peptide
Peptidyl-Dipeptidase A
Glomerular Filtration Rate
Angiotensin-Converting Enzyme Inhibitors
Edema

Keywords

  • Arteriovenous fistula
  • Atrial natriuretic factor
  • Converting-enzyme inhibitor
  • Kidney function
  • Renin-angiotensin system
  • Sodium reabsorption

ASJC Scopus subject areas

  • Physiology

Cite this

Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. / Abassi, Z.; Haramati, A.; Hoffman, A.; Burnett, John C Jr.; Winaver, J.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 259, No. 1 28-1, 1990.

Research output: Contribution to journalArticle

@article{ae5d3fa3dd054b7d9c2cdd6c48435ca8,
title = "Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure",
abstract = "Increased activity of the renin-angiotensin system is thought to play a major role in the pathogenesis of salt retention and edema formation in congestive heart failure. The present study evaluates the effects of chronic inhibition of angiotensin-converting enzyme on the response to infusion of exogenous atrial natriuretic factor (ANF) in salt-retaining rats with chronic arteriovenous (a-v) fistula, an experimental model of high-output congestive heart failure. Administration of ANF in incremental doses (5-50 μg·kg-1·h-1) to Inactin-anesthetized, sham-operated control rats resulted in dose-dependent increases in flow, sodium excretion, and glomerular filtration rate, and significant decreases in mean arterial blood pressure. These effects of atrial peptide were markedly attenuated in salt-retaining rats with a-v fistula. However, chronic oral treatment with the angiotensin-converting-enzyme inhibitor enalapril restored the natriuretic response of sodium-retaining rats with a-v fistula to high doses of ANF. At a dose of 50 μg·kg-1·h-1, fractional excretion of Na (FE(Na) in a-v fistula rats given enalapril was 4.0 ± 0.5{\%}, which was significantly greater than that in a-v fistula rats without enalapril (0.5 ± 0.4{\%}, P < 0.05) and not different from the response in sham-control rats (4.9 ± 0.7{\%}). The improvement in the natriuretic response after enalapril was not associated with a significant increase in GFR and occurred despite a decrease in mean arterial pressure. Moreover, chronic enalapril treatment did not significantly alter the plasma levels of immunoreactive ANF in either the sham controls or in the rats with a-v fistula. These data demonstrate that chronic converting-enzyme inhibition restores the natriuretic action of synthetic ANF in anesthetized rats with experimental heart failure. The data further suggest that increased activity of the renin-angiotensin system plays an important role in mediating the blunted natriuretic response to ANF in this experimental model of heart failure.",
keywords = "Arteriovenous fistula, Atrial natriuretic factor, Converting-enzyme inhibitor, Kidney function, Renin-angiotensin system, Sodium reabsorption",
author = "Z. Abassi and A. Haramati and A. Hoffman and Burnett, {John C Jr.} and J. Winaver",
year = "1990",
language = "English (US)",
volume = "259",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "1 28-1",

}

TY - JOUR

T1 - Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure

AU - Abassi, Z.

AU - Haramati, A.

AU - Hoffman, A.

AU - Burnett, John C Jr.

AU - Winaver, J.

PY - 1990

Y1 - 1990

N2 - Increased activity of the renin-angiotensin system is thought to play a major role in the pathogenesis of salt retention and edema formation in congestive heart failure. The present study evaluates the effects of chronic inhibition of angiotensin-converting enzyme on the response to infusion of exogenous atrial natriuretic factor (ANF) in salt-retaining rats with chronic arteriovenous (a-v) fistula, an experimental model of high-output congestive heart failure. Administration of ANF in incremental doses (5-50 μg·kg-1·h-1) to Inactin-anesthetized, sham-operated control rats resulted in dose-dependent increases in flow, sodium excretion, and glomerular filtration rate, and significant decreases in mean arterial blood pressure. These effects of atrial peptide were markedly attenuated in salt-retaining rats with a-v fistula. However, chronic oral treatment with the angiotensin-converting-enzyme inhibitor enalapril restored the natriuretic response of sodium-retaining rats with a-v fistula to high doses of ANF. At a dose of 50 μg·kg-1·h-1, fractional excretion of Na (FE(Na) in a-v fistula rats given enalapril was 4.0 ± 0.5%, which was significantly greater than that in a-v fistula rats without enalapril (0.5 ± 0.4%, P < 0.05) and not different from the response in sham-control rats (4.9 ± 0.7%). The improvement in the natriuretic response after enalapril was not associated with a significant increase in GFR and occurred despite a decrease in mean arterial pressure. Moreover, chronic enalapril treatment did not significantly alter the plasma levels of immunoreactive ANF in either the sham controls or in the rats with a-v fistula. These data demonstrate that chronic converting-enzyme inhibition restores the natriuretic action of synthetic ANF in anesthetized rats with experimental heart failure. The data further suggest that increased activity of the renin-angiotensin system plays an important role in mediating the blunted natriuretic response to ANF in this experimental model of heart failure.

AB - Increased activity of the renin-angiotensin system is thought to play a major role in the pathogenesis of salt retention and edema formation in congestive heart failure. The present study evaluates the effects of chronic inhibition of angiotensin-converting enzyme on the response to infusion of exogenous atrial natriuretic factor (ANF) in salt-retaining rats with chronic arteriovenous (a-v) fistula, an experimental model of high-output congestive heart failure. Administration of ANF in incremental doses (5-50 μg·kg-1·h-1) to Inactin-anesthetized, sham-operated control rats resulted in dose-dependent increases in flow, sodium excretion, and glomerular filtration rate, and significant decreases in mean arterial blood pressure. These effects of atrial peptide were markedly attenuated in salt-retaining rats with a-v fistula. However, chronic oral treatment with the angiotensin-converting-enzyme inhibitor enalapril restored the natriuretic response of sodium-retaining rats with a-v fistula to high doses of ANF. At a dose of 50 μg·kg-1·h-1, fractional excretion of Na (FE(Na) in a-v fistula rats given enalapril was 4.0 ± 0.5%, which was significantly greater than that in a-v fistula rats without enalapril (0.5 ± 0.4%, P < 0.05) and not different from the response in sham-control rats (4.9 ± 0.7%). The improvement in the natriuretic response after enalapril was not associated with a significant increase in GFR and occurred despite a decrease in mean arterial pressure. Moreover, chronic enalapril treatment did not significantly alter the plasma levels of immunoreactive ANF in either the sham controls or in the rats with a-v fistula. These data demonstrate that chronic converting-enzyme inhibition restores the natriuretic action of synthetic ANF in anesthetized rats with experimental heart failure. The data further suggest that increased activity of the renin-angiotensin system plays an important role in mediating the blunted natriuretic response to ANF in this experimental model of heart failure.

KW - Arteriovenous fistula

KW - Atrial natriuretic factor

KW - Converting-enzyme inhibitor

KW - Kidney function

KW - Renin-angiotensin system

KW - Sodium reabsorption

UR - http://www.scopus.com/inward/record.url?scp=0025079988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025079988&partnerID=8YFLogxK

M3 - Article

C2 - 2142862

AN - SCOPUS:0025079988

VL - 259

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 1 28-1

ER -